1993
DOI: 10.1016/0960-8966(93)90083-v
|View full text |Cite
|
Sign up to set email alerts
|

Protein truncation test (PTT) to rapidly screen the DMD gene for translation terminating mutations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
23
0
1

Year Published

1999
1999
2019
2019

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 57 publications
(24 citation statements)
references
References 2 publications
0
23
0
1
Order By: Relevance
“…As its performance clearly outperforms the Beggs and Chamberlain multiplex-PCR test 6,7 it should be considered as the method of choice for a first DNA analysis of DMD/BMD patients. After a negative MLPA-test, the gene can be scanned for point mutations using RNA 21,22 or DNA-based tests. 23 -25 …”
Section: Discussionmentioning
confidence: 99%
“…As its performance clearly outperforms the Beggs and Chamberlain multiplex-PCR test 6,7 it should be considered as the method of choice for a first DNA analysis of DMD/BMD patients. After a negative MLPA-test, the gene can be scanned for point mutations using RNA 21,22 or DNA-based tests. 23 -25 …”
Section: Discussionmentioning
confidence: 99%
“…Numerous methods have been applied to scan the DMD gene for nucleotide changes, including: SSCP [11], dHPLC [12], FM-CSCE [13], PTT [14], HRM [15]. These pre-screens aim to offer a lower cost alternative to sequencing all the 79 DMD exons, however, since the cost of sequencing has reduced dramatically over recent years it may be more appropriate to sequence the full gene now [16].…”
Section: Testing For Other Mutation Typesmentioning
confidence: 99%
“…A meeting of 29 senior scientists from Europe, the USA, India and Australia, was held in Naarden, The Netherlands on November [14][15][16]2008, to establish consensus Best Practice Guidelines for molecular diagnosis of Duchenne and Becker muscular dystrophy (DMD/BMD). New therapeutic trials for DMD demand accurate diagnosis of the disorder, especially where the therapy is targeted towards specific mutations.…”
Section: Introductionmentioning
confidence: 99%
“…Hence, there is extensive reliance on rapid screening techniques to quickly detect the subset of samples with apparent changes and that therefore merit sequencing. Many techniques have been developed for the detection of DNA sequence variations including the protein truncation test (PTT), 1 denaturing gradient gel electrophoresis (DGGE), 2 chemical cleavage of mismatches, 3 single-strand conformation polymorphism (SSCP), 4 2-dimensional gene scanning, 5 denaturing high-performance liquid chromatography (D-HPLC), 6 and conformation-sensitive gel electrophoresis (CSGE). 7 A detailed evaluation of the advantages and disadvantages of the current techniques indicates that some rapid screening techniques are too expensive (DGGE) or are not amenable to high throughput (DGGE and PTT).…”
mentioning
confidence: 99%